摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-deoxy-5'-N-piperidinouridine | 1119504-22-1

中文名称
——
中文别名
——
英文名称
5'-deoxy-5'-N-piperidinouridine
英文别名
5''-deoxy-5''-N-piperidinouridine;1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(piperidin-1-ylmethyl)oxolan-2-yl]pyrimidine-2,4-dione
5'-deoxy-5'-N-piperidinouridine化学式
CAS
1119504-22-1
化学式
C14H21N3O5
mdl
——
分子量
311.338
InChiKey
PJCAMYRNNJAIMT-OJAKKHQRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.71
  • 拓扑面积:
    102
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1-[(3aR,4R,6R,6aR)-2,2-dimethyl-6-(piperidin-1-ylmethyl)-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]pyrimidine-2,4-dione三氟乙酸 作用下, 以 为溶剂, 反应 0.5h, 以69%的产率得到5'-deoxy-5'-N-piperidinouridine
    参考文献:
    名称:
    Morpholino, Piperidino, and Pyrrolidino Derivatives of Pyrimidine Nucleosides as Inhibitors of Ribonuclease A: Synthesis, Biochemical, and Crystallographic Evaluation,
    摘要:
    Six 5'-deoxy-5'-morpholine, piperidine, and pyrrolidine of pyrimidine nucleosides have been synthesized and characterized. Their inhibitory action to ribonuclease A has been studied by biochemical analysis and X-ray crystallography. These compounds are moderate inhibitors of RNase A with mid-to-upper micromolar inhibition constants (K(i)). The high resolution X-ray crystal structures of the RNase A-inhibitor complexes have shown that all inhibitors bind at the enzyme catalytic cleft with the pyrimidine nucleobase at the B(1)R(2) subsites while the 5' group binds away from the main subsite P(1), where P-O(5') bond cleavage occurs, toward the solvent close to subsite P(0). Structure-activity relationship analysis has demonstrated that the compounds with the larger group in the 5' position are more potent. Comparative structural analysis of these RNase A complexes with other similar RNase A-ligand complexes provides a structural explanation of their potency and suggests ways to improve their efficiency and selectivity. These inhibitors can be the starting point for the development of compounds that can be used as pharmaceuticals against pathologies associated with RNase A homologues such as human angiogenin, which is implicated in tumor induced neovascularization.
    DOI:
    10.1021/jm800724t
点击查看最新优质反应信息

文献信息

  • Morpholino, Piperidino, and Pyrrolidino Derivatives of Pyrimidine Nucleosides as Inhibitors of Ribonuclease A: Synthesis, Biochemical, and Crystallographic Evaluation<sup>,</sup>
    作者:Anirban Samanta、Demetres D. Leonidas、Swagata Dasgupta、Tanmaya Pathak、Spyros E. Zographos、Nikos G. Oikonomakos
    DOI:10.1021/jm800724t
    日期:2009.2.26
    Six 5'-deoxy-5'-morpholine, piperidine, and pyrrolidine of pyrimidine nucleosides have been synthesized and characterized. Their inhibitory action to ribonuclease A has been studied by biochemical analysis and X-ray crystallography. These compounds are moderate inhibitors of RNase A with mid-to-upper micromolar inhibition constants (K(i)). The high resolution X-ray crystal structures of the RNase A-inhibitor complexes have shown that all inhibitors bind at the enzyme catalytic cleft with the pyrimidine nucleobase at the B(1)R(2) subsites while the 5' group binds away from the main subsite P(1), where P-O(5') bond cleavage occurs, toward the solvent close to subsite P(0). Structure-activity relationship analysis has demonstrated that the compounds with the larger group in the 5' position are more potent. Comparative structural analysis of these RNase A complexes with other similar RNase A-ligand complexes provides a structural explanation of their potency and suggests ways to improve their efficiency and selectivity. These inhibitors can be the starting point for the development of compounds that can be used as pharmaceuticals against pathologies associated with RNase A homologues such as human angiogenin, which is implicated in tumor induced neovascularization.
查看更多

同类化合物

西奈芬净 腺苷硒基蛋氨酸 脱氧腺嘌呤核苷 甲硫腺苷 环西奈芬净 尿嘧啶多氧菌素 C 多氧菌素 去氧氟尿苷 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨-d11 卡培他滨 化合物55 加洛他滨 [2-(癸酰氨基)-3-羟基-3-苯基丙基]N-[2-[[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基]-2-氧代乙基]氨基甲酸酯 S-腺苷蛋氨酸对甲苯磺酸硫酸盐 S-腺苷蛋氨酸丁二磺酸盐 S-腺苷蛋氨酸 S-腺苷甲硫氨酸对甲苯磺酸盐 S-腺苷基-L-蛋氨碘盐 S-腺苷乙硫氨酸 S-腺苷-L-蛋氨酸 S-腺苷-L-半胱氨酸 S-腺苷-3-硫代丙胺 S-腺苷-3-甲硫基丙胺 S-甲基-5'-甲硫基腺苷 S-(5’-腺苷基)-L-氯化蛋氨酸 S-(5'-腺苷)-L-高半胱氨酸 N-双环[2.2.1]-2-庚基-5-氯-5-脱氧腺苷酸 N-[6-[2-[[(2S,3S,4R,5R)-3,4-二羟基-5-[6-[(4-硝基苯基)甲基氨基]嘌呤-9-基]四氢呋喃-2-基]甲硫基]乙基氨基]-6-氧代己基]-3',6'-二羟基-3-氧代螺[2-苯并呋喃-1,9'-氧杂蒽]-5-甲酰胺 N(4)-腺苷-N(4)-甲基-2,4-二氨基丁酸 9-{5-[(3-氨基-3-羧基丙基)(甲基)-lambda4-硫基]-5-脱氧呋喃戊糖基}-9H-嘌呤-6-胺 9-[(2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基]-3H-嘌呤-2,6-二酮 9-(5-脱氧-beta-D-核-呋喃己糖基)-9H-嘌呤-6-胺 9-(5',6'-二脱氧-beta-己-5'-炔呋喃核糖基)腺嘌呤 8-氨基[1”-(N”-丹磺酰)-4”-氨基丁基]-5’-(1-氮丙啶基)-5’-脱氧腺苷 6-氨基-9-(5-脱氧-alpha-D-呋喃木糖基)-9H-嘌呤 5′-氨基-5′-脱氧腺苷对甲苯磺酸盐 5’-脱氧-5-氟胞嘧啶核苷 5-碘-5-脱氧环磷腺苷 5-氯-5-脱氧肌苷 5-氨基腺苷酸 5-氨基-1,5-二脱氧-1-(1,2,3,4-四氢-5-羟基甲基-2,4-二氧代嘧啶-1-基)-beta-D-别呋喃糖醛酸 5'-脱氧鸟苷 5'-脱氧尿苷 5'-脱氧-5-氟-N-[(戊氧基)羰基]胞苷 2',3'-二乙酸酯 5'-脱氧-5-氟-N-[(2-甲基丁氧基)羰基]胞苷 5'-脱氧-5'-碘尿苷 5'-脱氧- 5 -氟-N -[(3-甲基丁)羰基]胞苷